id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-D-0880-0001,FDA,FDA-2012-D-0880,"Draft Guidances for Industry: Generic Drug User Fee Amendments of 2012, Questions and Answers",Notice,Notice of Availability,2012-08-27T04:00:00Z,2012,8,2012-08-27T04:00:00Z,2012-10-27T03:59:59Z,2012-10-02T02:01:15Z,2012-20944,0,0,09000064810f2477
FDA-2012-D-0880-0002,FDA,FDA-2012-D-0880,"Draft Guidances for Industry: Generic Drug User Fee Amendments of 2012, Questions and Answers",Other,Guidance,2012-08-27T04:00:00Z,2012,8,2012-08-27T04:00:00Z,,2024-11-12T04:51:37Z,,1,0,09000064810f272a